Insider buying
~$1.4K1,000 sh @ $1.37
Traded Feb 17 · filed the same day
The CFO of Iridex paid $1.4K out of pocket for Iridex shares. 1 other person at Iridex bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jan 21, 2026 · Filed Jan 22, 2026
The CFO of Iridex paid $2.6K out of pocket for Iridex shares. 1 other person at Iridex bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$2,608
Shares × reported transaction price
<$25K
+1.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 14 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2026 ($403K)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-24. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
9 days after results of Jan 12, 2026, 64 days before results of Mar 26, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1.56 on Jan 21, 2026, 97% above its 52-week low and 8% below its high, after a 66% rise over the previous 30 trading days
52-week range $0.7901 (Mar 20, 2025) to $1.69 (Jan 22, 2025), 86% of the way up, from 251 adjusted closes. 30 trading days earlier: $0.9403 on Dec 5, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | 0.0% | +0.7% | −0.7% |
| 30 days | −5.4% | −1.0% | −4.4% |
| 90 days | −29.5% | +3.2% | −32.8% |
| 180 days | −38.6% | +8.6% | −47.2% |
Past results only. Not a forecast.
Insider buying
Traded Feb 17 · filed the same day
The CFO of Iridex paid $1.4K out of pocket for Iridex shares. 1 other person at Iridex bought some too, in the same month.
Insider buying
Traded Feb 17 · filed the same day
The CFO of Iridex paid $1.6K out of pocket for Iridex shares. 1 other person at Iridex bought some too, in the same month.
Insider buying
Traded Feb 12 · filed the same day
The CFO of Iridex paid $2.1K out of pocket for Iridex shares. 1 other person at Iridex bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Romeo R Dizon, Chief Financial Officer's past purchases, 90 days after disclosure: 65 buys, median −26.1 pts vs S&P 500, beat it 25 of 65 times. Past results, not a forecast.